All
Immunotherapy Plus Chemo Boosts Event-Free Survival in Resectable Lung Cancer
January 18th 2023Patients with operable non-small cell lung cancer who were treated with an anti-PD-1 monoclonal antibody plus a doublet chemotherapy regiment did not experience cancer recurrence or new symptom onset during follow-up in a recent study.
Beta-Blockers May Improve Post-Surgical Survival in Women With Ovarian Cancer, Heart Conditions
January 18th 2023Women who were taking beta-blockers, a medicine to treat heart conditions like high blood pressure, among others, near the time of surgery for epithelial ovarian cancer may confer a survival benefit years after undergoing a procedure.
Chemo-Related Hearing Loss May Have Emotional, Social Impacts in Testicular Cancer Survivors
January 12th 2023Testicular cancer survivors who were treated with cisplatin-based chemotherapy may have hearing loss or ringing of the ears, which may significantly affect certain parts of life including sleep and concentration, among other factors.